Medicare Enrolled
Dr. Thomas Hong, MD
Cardiovascular Disease · Houston, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hong? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hong
Dr. Thomas Hong is a cardiovascular disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Hong performed 5,028 Medicare services across 2,346 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hong received a total of $85,679 from 30 pharmaceutical and/or device companies across 2058 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hong is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 16% volume in TX$ $85,679 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,028
Medicare services
Top 16% in TX for cardiovascular disease
2,346
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~251 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 1,294 | $19 | $110 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 628 | $27 | $168 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 531 | $20 | $125 |
| Remote pacemaker monitoring, 90 days | 464 | $22 | $94 |
| EKG interpretation and report | 332 | $6 | $40 |
| Office visit, established patient (20-29 min) | 262 | $63 | $110 |
| New patient office visit, complex (60-74 min) | 145 | $164 | $476 |
| Office visit, established patient (30-39 min) | 137 | $100 | $145 |
| Ultrasonic guidance for blood vessel access | 105 | $11 | $40 |
| Hospital follow-up visit, moderate complexity | 99 | $63 | $150 |
| Programming of dual lead pacemaker system | 98 | $57 | $166 |
| Office visit, established patient, complex (40-54 min) | 84 | $132 | $215 |
| Hospital discharge day management, 30 minutes or less | 75 | $65 | $85 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 69 | $767 | $2,700 |
| Evaluation of cardiac rhythm monitor system | 59 | $36 | $105 |
| New patient office visit (45-59 min) | 53 | $115 | $396 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 47 | $245 | $1,025 |
| Remote pacemaker/defibrillator monitoring, 90 days | 46 | $14 | $90 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 46 | $25 | $125 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 45 | $16 | $65 |
| Initial hospital admission, moderate complexity | 35 | $105 | $167 |
| Programming of multiple lead implantable defibrillator system | 31 | $74 | $257 |
| Programming of dual lead implantable defibrillator system | 27 | $78 | $220 |
| Hospital discharge management, 30+ min | 27 | $92 | $175 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 26 | $414 | $2,327 |
| Electrocardiogram (EKG), 12-lead | 26 | $12 | $125 |
| External shock to heart to regulate heart beat | 25 | $86 | $440 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 25 | $59 | $435 |
| Initial hospital admission, high complexity | 25 | $140 | $300 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $673 | $2,345 |
| Insertion of heart rhythm monitor under skin | 19 | $3,519 | $12,000 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 18 | $675 | $2,050 |
| Repair of left upper heart chamber with implant with review by radiologist | 16 | $619 | $2,100 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 15 | $249 | $1,025 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $289 | $890 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $377 | $1,500 |
| Hospital follow-up visit, high complexity | 13 | $96 | $175 |
| Removal and replacement of multiple lead defibrillator | 11 | $329 | $1,000 |
| Programming of heart rhythm stimulation after drug infusion | 11 | $66 | $390 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $10 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.3% high complexity
0.5% medium
70.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$85,679
Total received (2018-2024)
Avg $12,240/year across 7 years
Top 7% in TX for cardiovascular disease
30
Companies
2,058
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$54,016 (63.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,779 (28.9%)
Other
Charitable contributions, space rental, and other categories
$5,583 (6.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,300 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$6,155
2023$5,843
2022$11,142
2021$7,443
2020$12,035
2019$11,493
2018$31,567
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$66,901
AngioDynamics, Inc.
$6,883
Biosense Webster, Inc.
$5,968
BIOTRONIK INC.
$1,428
Boston Scientific Corporation
$1,006
BOSTON SCIENTIFIC CORPORATION
$931
Medtronic, Inc.
$400
PFIZER INC.
$311
Nevro Corp.
$204
Medtronic Vascular, Inc.
$187
Stimwave Technologies Incorporated
$180
Janssen Pharmaceuticals, Inc
$174
Elutia, Inc.
$174
E.R. Squibb & Sons, L.L.C.
$154
Acutus Medical, Inc.
$135
Tactile Systems Technology Inc
$103
SANOFI-AVENTIS U.S. LLC
$93
Bardy Diagnostics, Inc.
$83
Stryker Corporation
$73
G Medical Diagnostic Services, Inc.
$63
Impulse Dynamics (USA) Inc.
$61
CARDIVA MEDICAL, INC.
$26
AltaThera Pharmaceuticals LLC
$23
Alnylam Pharmaceuticals Inc.
$21
AtriCure, Inc.
$19
Aziyo Biologics, Inc.
$17
iRhythm Technologies, Inc.
$17
Avinger Inc.
$16
GE HealthCare
$15
HeartFlow, Inc.
$14
Top 3 companies account for 93.1% of total payments
Associated products mentioned in payments ›
ACCENT · ACCOLADE SR · ADVANCED PRODUCT DEVELOPMENT · AFFERA MAPPING SYSTEM · AGILIS HISPRO · ALLURE · ALLURE QUADRA · AMPLATZER AMULET · ASSURITY · AVEIR · AZURE XT DR MRI SURESCAN · Ablation Therapy Hardware · Accent Pacemaker · Acticor · Advisor Catheter · Agilis NxT EP Introducer · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Assurity Pacemaker · Auryon Laser System 100-120 Vac · Azure · BodyGuardian · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · CRT-Ds · CRT-Ps · Cardiac Mapping System · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · CareLink Express · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Carto CFAE · Carto Smarttouch · CartoSound · Cartomerge · Cartoreplay · Confidense · Confirm Rx · Cool Point Irrigation Pump · DURATA · Durata Defibrillation ICD Lead · ECM · ECM Patch · ELIQUIS · EMBLEM MRI S-ICD · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENSITE · ENSITE PRECISION · EP-WorkMate Claris System · EPI-SENSE GUIDED COAGULATION SYS · Edora · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FORTIFY ASSURA · Flexitouch Plus · Fortify Assura · GALLANT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Brady · HAWKONE · HeartMate 3 Left Ventricular Assist Device · ICDs · JOT DX · LATITUDE · LATITUDE Communicator Power Supply · LUX DX · LUX-Dx Insertable Cardiac Monitor · MERLIN@HOME · MITRACLIP · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · MitraClip System · NSE - CUTTING ACCESSORIES · NUVISION ICE CATHETER · ONPATTRO · OPTISURE · Octrode SCS Leads · Optimizer · Optimizer Smart System · PANTHERIS · Pacemakers · Paso · Pouch · Proclaim Family of SCS IPGs · QDOT MICRO Catheter · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RHYTHMIA · Rivacor · SCS IPGs · SENSOR ENABLED · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · Senza Spinal Cord Stimulation System · Solia · Sotalol Hydrochloride · TACTICATH ABLATION CATHETER · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TactiCath Quartz CFA Catheter · UNIFY ASSURA · Unify Assura CRT Defibrillator · VISITAG SURPOINT External Processing Unit · VYNDAQEL · Visitag · WATCHMAN · WATCHMAN FLX · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XARELTO · ZEPHYR · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (63%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for cardiovascular disease in TX.
Equivalent to $1,704 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
396
Per 100K population
8.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hong is a remote & electrophysiology specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (consulting-driven, top 7%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hong experienced with evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days?
Based on Medicare claims data, Dr. Hong performed 1,294 evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hong receive payments from pharmaceutical companies?
Yes. Dr. Hong received a total of $85,679 from 30 companies across 2,058 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hong's costs compare to other cardiovascular diseases in Houston?
Dr. Hong's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology